IL-6 induced by staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 936-946

  Ahmed, E B ^a   Wang, T ^a   Daniels, M ^a   Alegre, M L ^a   Chong, A S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bacterial infection; donor specific alloreactivity; donor specific transfusion; immune regulation; immunosuppression; transplant immunology and tolerance; transplant rejection

Indexed keywords

CD40 LIGAND; CYCLOSPORIN; CYTOKINE; INTERLEUKIN 6; METHYLPREDNISOLONE; RAPAMYCIN;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS INFECTION; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; TH17 CELL;

ANIMALS; CD40 LIGAND; CYTOKINES; FEMALE; GRAFT SURVIVAL; INFLAMMATION; INTERLEUKIN-6; METHYLPREDNISOLONE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PSEUDOMONAS AERUGINOSA; SKIN TRANSPLANTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TH17 CELLS;

EID: 79955540193     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03476.x     Document Type: Article

References (59)

1. Wang T, Chen L, Ahmed E, et al,. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 2008; 180: 5991-5999.
2. Allison AC,. Immunosuppressive drugs: The first 50 years and a glance forward. Immunopharmacology 2000; 47: 63-83. (Pubitemid 30394533)
3. Fehr T, Sykes M,. Tolerance induction in clinical transplantation. Transpl Immunol 2004; 13: 117-130. (Pubitemid 39222026)
4. Greenwald RJ, Freeman GJ, Sharpe AH,. The B7 family revisited. Annu Rev Immunol 2005; 23: 515-548. (Pubitemid 40563179)
5. Yamada AA, Sayegh MH,. The CD154-CD40 costimulatory pathway in transplantation. Transplantation 2002; 73 (Suppl 1): S36-39. (Pubitemid 34094673)
6. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ,. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22: 307-328. (Pubitemid 38680425)
7. Monk NJ, Hargreaves RE, Marsh JE, et al,. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med 2003; 9: 1275-1280. (Pubitemid 37279850)
8. Reinke P, Fietze E, Ode-Hakim S, et al,. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737-1738.
9. McLaughlin K, Wu C, Fick G, Muirhead N, Hollomby D, Jevnikar A,. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation 2002; 74: 813-816.
10. Sageda S, Nordal KP, Hartmann A, et al,. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002; 2: 850-856. (Pubitemid 36306840)
11. Vilchez RA, Dauber J, McCurry K, Iacono A, Kusne S,. Parainfluenza virus infection in adult lung transplant recipients: An emergent clinical syndrome with implications on allograft function. Am J Transplant 2003; 3: 116-120. (Pubitemid 36323108)
12. Ahmed EB, Chong, AS, Alegre, M, The role of bacterial infections in allograft rejection. Expert Rev Clin Immunol 2008; 4: 281-293. (Pubitemid 351903286)
13. Wang T, Ahmed EB, Chen L, et al,. Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant 2010; 10: 1524-1533.
14. Fishman JA, Rubin RH,. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751. (Pubitemid 28268592)
15. Lowy FD,. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
16. von Eiff C, Becker K, Machka K, Stammer H, Peters G,. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344: 11-16. (Pubitemid 32064839)
17. Diekema DJ, Pfaller MA, Schmitz FJ, et al,. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): S114-132. (Pubitemid 32424266)
18. Nampoory MR, Johny KV, Costandy JN, et al,. Infection related renal impairment: A major cause of acute allograft dysfunction. Exp Clin Transplant 2003; 1: 60-64.
19. Adachi O, Kawai T, Takeda K, et al,. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143-150. (Pubitemid 28361303)
20. Bae T, Banger AK, Wallace A, et al,. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci U S A 2004; 101: 12312-12317. (Pubitemid 39145440)
21. Lien E, Sellati TJ, Yoshimura A, et al,. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419-33425. (Pubitemid 129511647)
22. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ,. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274: 17406-17409.
23. Takeuchi O, Hoshino K, Akira S,. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392-5396.
24. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D,. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5. (Pubitemid 29295815)
25. Miller LS, O'Connell RM, Gutierrez MA, et al,. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006; 24: 79-91. (Pubitemid 43077202)
26. Issa F, Schiopu A, Wood KJ,. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol; 6: 155-169.
27. Lin L, Ibrahim AS, Xu X, et al,. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009; 5: e1000703.
28. Ma CS, Chew GY, Simpson N, et al,. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008; 205: 1551-1557. (Pubitemid 351962018)
29. Markees TG, Phillips NE, Gordon EJ, et al,. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest 1998; 101: 2446-2455. (Pubitemid 28270439)
30. Herweijer H, Wolff JA,. Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther 2003; 10: 453-458. (Pubitemid 36395262)
31. Knapp JE, Liu D,. Hydrodynamic delivery of DNA. Methods Mol Biol 2004; 245: 245-250.
32. Pan H, Hong F, Radaeva S, Gao B,. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 2004; 1: 43-49.
33. Yazawa H, Murakami T, Li HM, et al,. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. Cancer Gene Ther 2006; 13: 993-1001. (Pubitemid 44564735)
34. Pasare C, Medzhitov R,. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036. (Pubitemid 36222922)
35. Bettelli E, Carrier Y, Gao W, et al,. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
36. Chen L, Ahmed, EB, Wang, T, et al,. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 2009; 182: 6217-6225.
37. Lund T, Fosby B, Korsgren O, et al,. Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int 2008; 21: 669-678. (Pubitemid 351852766)
38. Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T,. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988; 141: 1543-1549.
39. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH,. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988; 140: 508-512.
40. Uyttenhove C, Coulie PG, Van Snick J,. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 1988; 167: 1417-1427.
41. Lotz M, Jirik F, Kabouridis P, et al,. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253-1258.
42. Garman RD, Jacobs KA, Clark SC, Raulet DH,. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci U S A 1987; 84: 7629-7633. (Pubitemid 18035722)
43. Longhi MP, Wright K, Lauder SN, et al,. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 2008; 4: e1000006.
44. Rochman I, Paul WE, Ben-Sasson SZ,. IL-6 increases primed cell expansion and survival. J Immunol 2005; 174: 4761-4767.
45. Mangan PR, Harrington LE, O'Quinn DB, et al,. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
46. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B,. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189. (Pubitemid 43214587)
47. Grohmann U, Van Snick J, Campanile F, et al,. IL-9 protects mice from Gram-negative bacterial shock: Suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J Immunol 2000; 164: 4197-4203. (Pubitemid 30215078)
48. Kobayashi M, Tsuda Y, Yoshida T, et al,. Bacterial sepsis and chemokines. Curr Drug Targets 2006; 7: 119-134.
49. Varma TK, Durham M, Murphey ED, et al,. Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect Immun 2005; 73: 7340-7347. (Pubitemid 41587635)
50. Bettelli E, Korn T, Kuchroo VK,. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19: 652-657. (Pubitemid 350236805)
51. Chen Z, O'Shea JJ,. Th17 cells: A new fate for differentiating helper T cells. Immunol Res 2008; 41: 87-102.
52. Takatori H, Kanno Y, Chen Z, O'Shea JJ,. New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 2008; 18: 533-541.
53. Fedtke I, Gotz F, Peschel A,. Bacterial evasion of innate host defenses-the Staphylococcus aureus lesson. Int J Med Microbiol 2004; 294: 189-194. (Pubitemid 39281049)
54. Woolard MD, Frelinger JA,. Outsmarting the host: Bacteria modulating the immune response. Immunol Res 2008; 41: 188-202.
55. Rooijakkers SH, van Strijp JA,. Bacterial complement evasion. Mol Immunol 2007; 44: 23-32. (Pubitemid 44647108)
56. Hornef MW, Normark S, Henriques-Normark B, Rhen M,. Bacterial evasion of innate defense at epithelial linings. Chem Immunol Allergy 2005; 86: 72-98. (Pubitemid 40904999)
57. Pieters J,. Evasion of host cell defense mechanisms by pathogenic bacteria. Curr Opin Immunol 2001; 13: 37-44. (Pubitemid 32096958)
58. Kaufmann SH,. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11: 129-163. (Pubitemid 23115004)
59. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C,. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009: CD005632.